This review explores recent advancements and applications of 3D printing in healthcare,
with a focus on personalized medicine, tissue engineering, and medical device production. It …

Dry powder inhaler (DPI) is an attractive dosage form for local and systemic pulmonary drug
delivery. However, designing DPIs with adequate physicochemical properties is …

With the great success of coronavirus disease (COVID-19) messenger ribonucleic acid
(mRNA) vaccines, mRNA therapeutics have gained significant momentum for the prevention …

Pulmonary drug delivery has the advantages of being rapid, efficient, and well-targeted, with
few systemic side effects. In addition, it is non-invasive and has good patient compliance …

Pulmonary diseases pose an immense threat to global health. Several nanotherapeutics-
based approaches aimed to tackle pulmonary ailments in recent years. The current …

Acute Lung Injury (ALI) is a life-threatening syndrome that has been identified as a potential
complication of COVID-19. There is a critical need to shed light on the underlying …

The capacity of SARS-CoV-2 to evolve poses challenges to conventional prevention and
treatment options such as vaccination and monoclonal antibodies, as they rely on viral …

Asthma is a heterogeneous inflammatory disease characterized by abnormalities in immune
response. Due to the inherent complexity of the disease and the presence of comorbidities …

High local delivery of anti-infectives to the lungs is required for activity against infections of
the lungs. The present pandemic has highlighted the potential of pulmonary delivery of anti …

Nanoparticles (NPs) have shown significant potential for pulmonary administration of
therapeutics for the treatment of chronic lung diseases in a localized and sustained manner …